Heart-Lung watch: can blood tests predict cancer treatment side effects?

NCT ID NCT06410300

Recruiting now Knowledge-focused Sponsor: Bo Lu Source: ClinicalTrials.gov ↗

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This study is testing whether regular heart and lung monitoring, along with blood samples, can predict side effects in people with lung cancer receiving radiation and immunotherapy. The goal is to find early warning signs of heart or lung damage before symptoms appear. The trial enrolls adults with locally advanced lung cancer who are scheduled for curative radiotherapy and immunotherapy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: curative radiotherapy and immunotherapy (checkpoint inhibitor)
What this could lead to: If successful, this could help doctors predict and prevent heart and lung side effects in lung cancer patients receiving radiation and immunotherapy.
What could go wrong: This is an early pilot study focused on finding markers, not testing a new treatment. The markers identified may not reliably predict side effects in larger groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm non-small cell lung carcinoma small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER

Contacts and locations

Locations

Rutgers Cancer Institute of New Jersey
RECRUITING

New Brunswick, New Jersey, 08901, United States
University of Missouri - Ellis Fischel Cancer Center
RECRUITING

Columbia, Missouri, 65212, United States
University of Rochester Medical Center
RECRUITING

Rochester, New York, 14642, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.